Jeffrey C. Glennon is a neuroscientist linking experimental psychology to biological mechanisms, with a track record in industry and academic settings. After completing his PhD in neurophysiology at University College Dublin, for nearly 10 years he was working as a pharmacologist in the pharmaceutical industry post-PhD at Solvay Pharmaceuticals. In 2010, he returned to academia in the Netherlands and later to Ireland. Today, he works as a Senior Conway Fellow and Assistant Professor at University College Dublin. His academic interests are in rule-making/rule-breaking processes in the cingulate cortex that govern rational versus emotional decision-making. As a translational neuroscientist, he seeks to implement basic and preclinical efforts into clinical practice relevant to patients. Further, he has led a EUR 4.5M EU Commission FP7-funded consortium (MATRICS) on conduct problems. In addition, he has been involved both as work package leader and as a partner in six Horizon 2020/Marie Curie ITN-funded/EU Innovative Medicines Initiative (IMI) II consortia focused on neurodevelopmental disorders, adult psychiatry, and psychiatric conditions in neurological and somatic disorders (type I myotonic dystrophy and type II diabetes).